ArticleCell discovery2024

Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphoma.

Wen Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.